One such condition is Sanfilippo syndrome, which creates significant hurdles for affected children and their families. This condition not only impacts physical development but also cognitive and ...
Bored Panda on MSN4mon
This Family Advocates For Rare Sanfilippo Syndrome In Hopes That Others Have Better ChancesAs Logan’s mom, Noelle, described: “Sanfilippo syndrome is a terminal, neurodegenerative rare disease. Children lose all the ...
Mackay says children with Sanfilippo syndrome have too much build-up of heparan sulfate in the lysosome of a cell. This build-up causes damage to the brain. “We know the cause, but what we don ...
An Orange couple who lost their son to a rare genetic condition are determined to continue raising awareness to improve the lives of diagnosed children and their families.
Dr. Eric Crombez, Chief Medical Officer at Ultragenyx, stated, "The data support UX111's potential to provide meaningful benefits to children with Sanfilippo Syndrome, especially for those in ...
Ultragenyx Pharmaceutical RARE reported new findings from an ongoing, pivotal study of its investigational candidate, UX111 (ABO-102) AAV gene therapy, for Sanfilippo syndrome type A (MPS IIIA).
The firm is seeking accelerated approval for UX111 using reductions in levels of heparan sulfate in cerebrospinal fluid as a surrogate endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback